Joshua T Kowalczyk

6PUBLICATIONS
39CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 13, 2024
Preclinical Therapeutic Efficacy of RAF/MEK/ERK and IGF1R/AKT/mTOR Inhibition in Neuroblastoma.

Stacey Stauffer, Jacob S Roth, Edjay R Hernandez

|Feb 24, 2024
KDM3B inhibitors disrupt the oncogenic activity of PAX3-FOXO1 in fusion-positive rhabdomyosarcoma.

Yong Yean Kim, Berkley E Gryder, Ranuka Sinniah

|May 11, 2023
Exploiting docetaxel-induced tumor cell necrosis with tumor targeted delivery of IL-12.

S Elizabeth Franks, Ginette S Santiago-Sanchez, Kellsye P Fabian

|Dec 23, 2022
Exploiting the immunogenic potential of standard of care radiation or cisplatin therapy in preclinical models of HPV-associated malignancies.

Joshua T Kowalczyk, Kellsye P Fabian, Michelle R Padget

|Dec 11, 2022
Dying of Stress: Chemotherapy, Radiotherapy, and Small-Molecule Inhibitors in Immunogenic Cell Death and Immunogenic Modulation.

Kellsye P Fabian, Joshua T Kowalczyk, Sandy T Reynolds

|Nov 07, 2020
Rigosertib Induces Mitotic Arrest and Apoptosis in RAS-Mutated Rhabdomyosarcoma and Neuroblastoma.

Joshua T Kowalczyk, Xiaolin Wan, Edjay R Hernandez

Pageof 1

Frequent Collaborators

3 joint publications

James W Hodge

2 joint publications

Xiaoling Luo

2 joint publications

Kellsye P Fabian

1 joint publications

Gaelyn C Lyons